AN ACT to amend Tennessee Code Annotated, Title 53, Chapter 11, relative to the use of buprenorphine products.

Where it is in the process

Plain-English Summary

As introduced, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.

Source: OpenStates · fetched April 24, 2026

Votes

Read full bill text →↓ Why am I seeing this?

Want updates?

Get notified when TN SB1848 moves stage

Pick a channel below. Every option is opt-in, and we tell you exactly what we store.

Email

Identified

We store your email address and the bill ID. We'll send a confirmation link first; alerts only start after you click it. Every email has a one-click unsubscribe.

Coming soon

RSS feed· Atom 1.0 + JSON Feed per bill
Bluesky· follow a CivicRadar bot post per status change
Telegram· channel or DM via bot
Discord· channel webhook
WhatsApp· via WhatsApp Business
SMS· via Twilio